Bioage Labs Inc (BIOA)

Jan 01, 2026

Can BioAge Labs Inc. stock deliver sustainable ROEQuarterly Earnings Review & Maximum Profit Growth - bollywoodhelpline.com

Jan 01, 2026

Dec 27, 2025

BioAge Labs upgraded to equal weight from underweight at Morgan Stanley - MSN

Dec 27, 2025

Dec 25, 2025

BIOA INVESTORS: Kirby McInerney LLP Reminds BioAge Labs, Inc. Investors of Important Deadline and Encourages Investors to Contact the Firm - TMX Newsfile

Dec 25, 2025

Dec 24, 2025

BioAge Labs (NASDAQ:BIOA) Sets New 52-Week HighStill a Buy? - MarketBeat

Dec 24, 2025

Dec 23, 2025

Cash per share of BioAge Labs, Inc. – FWB:Y7G - TradingView — Track All Markets

Dec 23, 2025

Dec 22, 2025

BioAge Labs, Inc.(NasdaqGS: BIOA) added to NASDAQ Biotechnology Index - marketscreener.com

Dec 22, 2025

Dec 21, 2025

BioAge Labs announces positive phase 1 trial results - MSN

Dec 21, 2025

Dec 20, 2025

BioAge Labs (BIOA) Price Target Increased by 24.14% to 12.24 - Nasdaq

Dec 20, 2025

Dec 20, 2025

Is BioAge Labs Inc. stock dividend yield sustainableJuly 2025 Catalysts & Real-Time Volume Trigger Notifications - Улправда

Dec 20, 2025

Dec 20, 2025

Can BioAge Labs Inc. stock continue upward trendMarket Activity Summary & Verified Momentum Stock Ideas - Улправда

Dec 20, 2025

Dec 19, 2025

Why BioAge Labs Inc. (Y7G) stock is listed among top recommendationsQuarterly Market Review & Risk Controlled Daily Trade Plans - DonanımHaber

Dec 19, 2025

Dec 19, 2025

What makes BioAge Labs Inc. stock attractive to growth fundsJuly 2025 Levels & Precise Swing Trade Alerts - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Can BioAge Labs Inc. stock withstand economic slowdown2025 Technical Overview & Technical Confirmation Alerts - DonanımHaber

Dec 19, 2025

Dec 19, 2025

How analysts rate BioAge Labs Inc. stock today2025 Volume Leaders & High Accuracy Investment Signals - DonanımHaber

Dec 19, 2025

Dec 15, 2025

Bioage Labs Earnings Notes - Trefis

Dec 15, 2025

Dec 13, 2025

2 Reasons I Wouldn't Touch BioAge Labs Stock With a 10-Foot Pole - The Globe and Mail

Dec 13, 2025

Dec 13, 2025

2 Reasons I Wouldn't Touch BioAge Labs Stock With a 10-Foot Pole - The Motley Fool

Dec 13, 2025

Dec 13, 2025

Bioage Labs Stock Rockets 52% With 8-Day Winning Streak - Trefis

Dec 13, 2025

Dec 12, 2025

Paul Rubin Sells 18,000 Shares of BioAge Labs (NASDAQ:BIOA) Stock - MarketBeat

Dec 12, 2025

Dec 11, 2025

BioAge Labs CMO Paul D. Rubin Sells 18,000 Shares - TradingView — Track All Markets

Dec 11, 2025

Dec 11, 2025

[Form 4] BioAge Labs, Inc. Insider Trading Activity - Stock Titan

Dec 11, 2025

Dec 09, 2025

Officer Rubin Files To Sell 18,000 Of BioAge Labs Inc [BIOA] - TradingView — Track All Markets

Dec 09, 2025

Dec 08, 2025

Morgan Stanley Upgrades BioAge Labs (BIOA) - Nasdaq

Dec 08, 2025

Dec 08, 2025

BioAge Labs (BIOA) Competitors and Alternatives 2025 - MarketBeat

Dec 08, 2025

Dec 07, 2025

Volume Recap: How BioAge Labs Inc stock reacts to Fed rate cutsFed Meeting & Technical Pattern Recognition Alerts - BỘ NỘI VỤ

Dec 07, 2025

Dec 06, 2025

Paul Rubin Sells 68,897 Shares of BioAge Labs (NASDAQ:BIOA) Stock - MarketBeat

Dec 06, 2025

Dec 06, 2025

BioAge Labs (NASDAQ:BIOA) Rating Increased to Hold at Wall Street Zen - MarketBeat

Dec 06, 2025

Dec 05, 2025

BioAge Labs CMO Paul D. Rubin Sells All Common Stock Holdings - TradingView

Dec 05, 2025

Dec 05, 2025

Officer Rubin Sells 68,897 ($701.9K) Of BioAge Labs Inc [BIOA] - TradingView

Dec 05, 2025

Dec 05, 2025

BioAge Labs stock rating upgraded by Morgan Stanley on promising BGE-102 data - Investing.com South Africa

Dec 05, 2025

Dec 05, 2025

How BioAge Labs Inc. stock reacts to Fed rate cutsShort Setup & Fast Gain Stock Trading Tips - Newser

Dec 05, 2025

Dec 05, 2025

BioAge’s NLRP3 inhibitor shows positive Phase 1 data in clinical trial - Investing.com Nigeria

Dec 05, 2025

Dec 05, 2025

Is BioAge Labs Inc. stock a safe haven assetQuarterly Earnings Summary & Safe Entry Zone Identification - Newser

Dec 05, 2025

Dec 05, 2025

Why BioAge Labs Inc. stock remains undervaluedCEO Change & Smart Money Movement Alerts - Newser

Dec 05, 2025

Dec 05, 2025

Analysts’ Opinions Are Mixed on These Healthcare Stocks: BioAge Labs, Inc. (BIOA) and Insulet (PODD) - The Globe and Mail

Dec 05, 2025

Dec 05, 2025

How BioAge Labs Inc. (Y7G) stock stacks up against competitorsInsider Selling & Daily Chart Pattern Signal Reports - Newser

Dec 05, 2025

Dec 04, 2025

Positive Developments and Promising Trials Bolster Buy Rating for BioAge Labs - TipRanks

Dec 04, 2025

Dec 04, 2025

Citi Maintains BioAge Labs(BIOA.US) With Buy Rating, Maintains Target Price $15 - 富途牛牛

Dec 04, 2025

Dec 04, 2025

Officer Rubin Files To Sell 68,897 Of BioAge Labs Inc [BIOA] - TradingView

Dec 04, 2025

Dec 04, 2025

Will BioAge Labs Inc. (Y7G) stock outperform global peersCEO Change & Safe Capital Investment Plans - Newser

Dec 04, 2025

Dec 04, 2025

Merger Talk: Is BioAge Labs Inc stock a safe haven assetPortfolio Growth Summary & Weekly Watchlist of Top Performers - BỘ NỘI VỤ

Dec 04, 2025

Dec 04, 2025

BioAge Labs BGE-102 Phase 1 Trial Shows Potential in Targeting Inflammation in Central Nervous System, Peripheral Tissues - marketscreener.com

Dec 04, 2025

Dec 04, 2025

BioAge Reports Positive Interim Phase 1 Data For BGE-102; Shares Rise - Nasdaq

Dec 04, 2025

Dec 04, 2025

BioAge Labs Announces Positive Phase 1 Trial Results - TipRanks

Dec 04, 2025